These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20807184)

  • 1. Tonapofylline: a selective adenosine-1 receptor antagonist for the treatment of heart failure.
    Ensor CR; Russell SD
    Expert Opin Pharmacother; 2010 Oct; 11(14):2405-15. PubMed ID: 20807184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function).
    Voors AA; Dittrich HC; Massie BM; DeLucca P; Mansoor GA; Metra M; Cotter G; Weatherley BD; Ponikowski P; Teerlink JR; Cleland JG; O'Connor CM; Givertz MM
    J Am Coll Cardiol; 2011 May; 57(19):1899-907. PubMed ID: 21545947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rolofylline: a selective adenosine 1 receptor antagonist for the treatment of heart failure.
    Slawsky MT; Givertz MM
    Expert Opin Pharmacother; 2009 Feb; 10(2):311-22. PubMed ID: 19236201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adenosine antagonism in the cardiorenal syndrome.
    Dohadwala MM; Givertz MM
    Cardiovasc Ther; 2008; 26(4):276-86. PubMed ID: 19035879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study.
    Gottlieb SS; Givertz MM; Metra M; Gergich K; Bird S; Jones-Burton C; Massie B; Cotter G; Ponikowski P; Weatherley B; O'Connor C; Dittrich H
    J Card Fail; 2010 Sep; 16(9):714-9. PubMed ID: 20797594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.
    Massie BM; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Weatherley BD; Cleland JG; Givertz MM; Voors A; DeLucca P; Mansoor GA; Salerno CM; Bloomfield DM; Dittrich HC;
    N Engl J Med; 2010 Oct; 363(15):1419-28. PubMed ID: 20925544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BG-9928 (Biogen Idec).
    Doggrell SA
    Curr Opin Investig Drugs; 2005 Sep; 6(9):962-8. PubMed ID: 16187697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
    Dittrich HC; Gupta DK; Hack TC; Dowling T; Callahan J; Thomson S
    J Card Fail; 2007 Oct; 13(8):609-17. PubMed ID: 17923351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A1 receptor antagonists in clinical research and development.
    Hocher B
    Kidney Int; 2010 Sep; 78(5):438-45. PubMed ID: 20592713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.
    Weatherley BD; Cotter G; Dittrich HC; DeLucca P; Mansoor GA; Bloomfield DM; Ponikowski P; O'Connor CM; Metra M; Massie BM;
    J Card Fail; 2010 Jan; 16(1):25-35. PubMed ID: 20123315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.
    Cotter G; Dittrich HC; Weatherley BD; Bloomfield DM; O'Connor CM; Metra M; Massie BM;
    J Card Fail; 2008 Oct; 14(8):631-40. PubMed ID: 18926433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A1 receptor antagonists at a fork in the road.
    Givertz MM
    Circ Heart Fail; 2009 Nov; 2(6):519-22. PubMed ID: 19919975
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of tonapofylline in subjects with severe renal impairment and in elderly subjects.
    Li Z; Tenhoor C; Marbury T; Swan S; Zhu Y; Ticho B
    Int J Clin Pharmacol Ther; 2011 Sep; 49(9):563-70. PubMed ID: 21888869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine1 receptor antagonism: a new therapeutic approach for the treatment of decompensated heart failure.
    Shah RH; Frishman WH
    Cardiol Rev; 2009; 17(3):125-31. PubMed ID: 19384086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale, design, and results from RENO-DEFEND 1: a randomized, dose-finding study of the selective A1 adenosine antagonist SLV320 in patients hospitalized with acute heart failure.
    Pang PS; Mehra M; Maggioni AP; Filippatos G; Middlebrooks J; Turlapaty P; Kazei D; Gheorghiade M;
    Am Heart J; 2011 Jun; 161(6):1012-23.e3. PubMed ID: 21641345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological treatment of chronic heart failure in patients with renal failure].
    Stawicki S; Starczewska MH; Roik M; Opolski G
    Kardiol Pol; 2005 Mar; 62(3):254-60. PubMed ID: 15830021
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of heart failure and preserved systolic function].
    Dahlström U; Boman K; Brodin LA; Hagerman I; Willenheimer R
    Lakartidningen; 2007 Aug 22-28; 104(34):2348-50. PubMed ID: 17907560
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
    J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of tonapofylline (BG9928), an adenosine A1 receptor antagonist, against cisplatin-induced acute kidney injury in rats.
    Gill A; Wortham K; Costa D; Davis W; Ticho B; Whalley E
    Am J Nephrol; 2009; 30(6):521-6. PubMed ID: 19828940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.